首页 正文

Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia

{{output}}
Background: While many humanized monoclonal antibodies utilize complement-dependent cytotoxicity, the complement depleting effects of these antibodies and the impact of complement replacement on treatment response are not well-de... ...